Empowered Funds LLC raised its position in shares of Owens & Minor, Inc. (NYSE:OMI – Free Report) by 5.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 337,766 shares of the company’s stock after purchasing an additional 17,152 shares during the quarter. Empowered Funds LLC owned 0.44% of Owens & Minor worth $5,300,000 at the end of the most recent quarter.
A number of other hedge funds also recently modified their holdings of the business. Quarry LP raised its position in Owens & Minor by 290.1% during the second quarter. Quarry LP now owns 2,099 shares of the company’s stock valued at $28,000 after buying an additional 1,561 shares during the period. Innealta Capital LLC acquired a new position in shares of Owens & Minor in the 2nd quarter valued at about $43,000. DekaBank Deutsche Girozentrale lifted its position in shares of Owens & Minor by 76.6% in the second quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company’s stock worth $43,000 after purchasing an additional 1,356 shares in the last quarter. Blue Trust Inc. boosted its holdings in shares of Owens & Minor by 176.8% during the third quarter. Blue Trust Inc. now owns 2,787 shares of the company’s stock worth $44,000 after purchasing an additional 1,780 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its position in Owens & Minor by 100.6% during the second quarter. Allspring Global Investments Holdings LLC now owns 6,071 shares of the company’s stock valued at $82,000 after purchasing an additional 3,044 shares in the last quarter. Hedge funds and other institutional investors own 98.04% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts have issued reports on the stock. UBS Group cut their target price on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Robert W. Baird reduced their price objective on Owens & Minor from $19.00 to $14.00 and set a “neutral” rating for the company in a research report on Tuesday, November 5th. StockNews.com downgraded Owens & Minor from a “buy” rating to a “hold” rating in a research note on Monday, August 26th. Citigroup cut their price target on Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research note on Tuesday, November 5th. Finally, JPMorgan Chase & Co. lowered their price target on Owens & Minor from $22.00 to $18.00 and set an “underweight” rating for the company in a research note on Wednesday, August 21st. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $18.50.
Owens & Minor Stock Performance
OMI opened at $12.26 on Monday. The stock has a 50-day moving average of $14.00 and a 200-day moving average of $15.43. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. Owens & Minor, Inc. has a 52-week low of $11.42 and a 52-week high of $28.35. The company has a market cap of $945.37 million, a PE ratio of -18.86, a price-to-earnings-growth ratio of 0.42 and a beta of 0.41.
Owens & Minor (NYSE:OMI – Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.41 by $0.01. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The company had revenue of $2.72 billion for the quarter, compared to the consensus estimate of $2.68 billion. During the same quarter last year, the company posted $0.44 earnings per share. The company’s revenue for the quarter was up 5.0% compared to the same quarter last year. As a group, equities research analysts forecast that Owens & Minor, Inc. will post 1.49 earnings per share for the current fiscal year.
Owens & Minor Company Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Recommended Stories
- Five stocks we like better than Owens & Minor
- Learn Technical Analysis Skills to Master the Stock Market
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Find and Profitably Trade Stocks at 52-Week Lows
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.